MONTREAL, Sept. 26, 2013 - JSS Medical Research, a full-service Contract Research Organization (CRO), announced today that it has acquired LatAm Clinical Trials, a multinational CRO in South and Central America.
LatAm Clinical Trials was founded by a group of entrepreneurs in 2005 and has provided clinical research support to the pharmaceutical industry for Phase I - IV and post-marketing studies with offices in the USA, Colombia and Panama. The clinical research staff is located in the Andean Countries of South America and in Central America, giving access to substantial underutilized medical expertise and infrastructure throughout an area that includes Colombia, Panama, Costa Rica,Guatemala, Dominican Republic, Peru, Venezuela and Ecuador. LatAm Clinical Trials' geographic reach is extended to additional countries in Latin America through partnerships with other local CROs in Mexico, Argentina, Brazil and Chile. The company has earned a reputation for providing high standard clinical research services including study start-up, regulatory support, project management, site management, monitoring, quality assurance and training.
LatAm brings quality and value to clients' clinical development programs by offering flexibility of services coupled with an extensive knowledge of Latin American clinical trial industry and regulatory requirements along with an extensive network of experienced clinical investigators. With eight years of experience, LatAm Clinical Trials is recognized as one of the leading regional CROs with established long term relationships in the pharmaceutical, medical devices, and biotechnology industries.
"It is an exciting and important day for JSS Medical Research," said Dr. John Sampalis, CEO and Founder of JSS Medical Research. "We are constantly improving our service offerings both in terms of geographic reach and scope of services by responding to the industry demands and the specific needs of our clientele. "The addition of LatAm Clinical Trials to JSS Medical Research solidifies our presence in Latin America allowing us to extend our services in the region and enhancing our current position by adding regional clinical services in addition to the already established scientific, data management, biostatistical, outcomes research, health economics and medical writing services."
The acquisition of LatAm Clinical Trials is a key milestone for JSS Medical Research in its route to becoming a leading international niche CRO that provides our clients with the best possible and un-compromised scientific and operational services. JSS Medical Research is a company that has been established on a scientific foundation and has built its clinical operations on this foundation. LatAm Clinical Trial's philosophy with emphasis on high quality clinical operations governed by high scientific rigor and the management team comprised of clinicians, epidemiologists and clinical researchers was entirely compatible with the JSS Medical Research vision. The synergies will allow us to continue offering clinical trial services for phase I - IV studies but will also enable us to assist our Industry and Government partners in designing and executing the much needed Post-Approval Clinical Epidemiological Programs."
"The pace of growth at JSS Medical Research sees us joining a company at a very exciting time and being part of this group will enable us to better leverage our expertise offering our local clients access to international sites and personnel with the highest possible level of scientific expertise and knowledge along with worldwide experience in clinical trial operations," said Dr. Diana Valencia, co-founder and CEO of LatAm Clinical Trials. "Both companies' business ethic is focused on a commitment to excellence and quality and this can only be reinforced by the combination of the two organizations."
About JSS Medical Research
JSS Medical Research is a full-service CRO with its corporate office in Canada and a regional office in Colombia. The company offers clinical trial management services in Phase I-IV trials in a broad range of therapeutic areas and is a leader in Post-Approval Clinical Epidemiology Studies (PACES) including Post-Marketing Observational Studies, Health Outcomes Research and Health Economics. Personalized services with one-on-one client attention from experienced senior scientific and clinical teams have established JSS Medical Research as a unique CRO worldwide. For more information, please visit our website at www.jssresearch.com.